The ConcertAI Podcast

In this episode, we're thrilled to have Dr. Andy Beck, the Co-founder and CEO of PathAI, one of the leading digital pathology companies, as our guest.Digital pathology is transforming the accessibility of decision rules and decision augmentation, creating translational assets and changing how clinical development occurs. Dr. Beck shares insights on the progress and life of digital pathology, and how it's transforming healthcare.With the level of data and insights available to medical professionals, clinical interpretation will move far earlier, bringing a sense of optimism for cancer patients everywhere.Tune in to this episode to learn about the future of clinical development, and how AI-based models derived from digital pathology are creating a new paradigm in healthcare. Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

In this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are changing the game.Bristol Myers Squibb's Marisa and Gaelan  share how their collaboration with ConcertAI on the Digitally Accelerated Clinical Trial Solution (DACT) is lowering the burden on patients and sites, and increasing the number of clinical trial types that can be run in community settings. The platform not only meets FDA imperatives but also makes much-needed medicines available to a wider array of patients.Join us as we dive deep into the exciting developments in clinical research and discover how technology is improving patient outcomes.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model. In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, and Gaelan Ritter, Head of Analytics Innovation and Digital Health, who shed light on the exciting ways clinical trials are evolving and improving patient outcomes. The team at Bristol Myers Squibb will be discussing their groundbreaking work using the Digitally Accelerated Clinical Trial (DACT) model in the biopharma industry which leverages automation and integrates with various clinical data sources to collect more data and improve trial efficiency. This not only allows for more rapid completion of trials, but also facilitates the identification of eligible patients.Join us as we explore these exciting developments and learn how they are changing the biopharma landscape.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

ConcertAI is grateful to have a presence in a geography with such a fast pace of technical innovation, and is excited for the future. Tune in to the latest episode of The ConcertAI Podcast, hosted by CEO Jeff Elton! This week's episode explores the topic of globalizing healthcare and biopharma technical innovation. Jeff and Jitendra Gupta talks about what it really means to be a global company, and the amazing progress that India has made in advancing the healthcare and biopharma technology industry. Don't miss out on this insightful episode!Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

In this episode of the ConcertAI podcast, join our CEO Jeff Elton and Dan McSweeney, President of TeraRecon, ConcertAI's digital imaging solution, for an informative and engaging discussion. TeraRecon is a leading solution for three-dimensional radiological interpretation, but what makes them stand out is their novel approach of integrating AI directly into care delivery models. Jeff and Dan explore the unique position of TeraRecon in the healthcare workflow and how their neutrality sets them apart from other players in the space. They also discuss the potential of AI in radiology and how it can reduce variation in clinical outcomes while increasing productivity.Don't miss out on this exciting exchange about healthcare technology and innovation. Tune in now to join the conversation!Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

Don't miss out on the latest episode of The ConcertAI Podcast featuring Catherine Richards, ConcertAI's chief data officer! Join us as we dive into the state of the field of real world data, why it's transforming, and how research is now enabled because of it. Tune in to gain more understanding about data sets and analyses derived from real world data. Click the link to listen now! Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

On this episode of The ConcertAI Podcast, we're  joined by SVP of Clinical Development Technologies, Luke Dunlap. Luke and Jeff discuss the experience and  transformation about how clinical trials are being conducted with some of the newest technologies and the value that's being realized. Take a deeper dive into our end-to-end software platform, Digital Trial Solutions, is being used to conduct pharmaceutical studies at clinical research sites and how it is subsequently reducing patient burden. You'll also hear about ConcertAI's Clinical Trial Optimization software system and how it is improving the efficiency of clinical research protocols. Learn how we are transforming and accelerating biomedical innovations over the course of the next two to five years. Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

On this episode we are joined by Dr. Warren Whyte. Dr. Whyte heads up ConcertAI's health equity and trial diversity initiatives through the ERACE (Engaging Research to Achieve Cancer Care Equity) program . As a leader in this field, his work and the work of his team has influenced all of what ConcertAI brings to clients, customers, and biopharma partners. This includes the integration of SDOH with all of our datasets - a first-in-class for anybody in the RWD Industry. His work also influenced integrating health equity and trial diversity considerations into all of our technology solutions. There couldn't be a more important topic with a more influential individual in the field!Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

On our first episode, special guest Claudio D'Ambrosio covers the topic of multi-modal data in biomedical research. Multi-modal data can allow some of the deepest most advanced research questions to be answered. We start with the questions and then we bring together layers of different data, of different origin, that surround the patient in service of that particular question. This will change and transform how we develop and test hypothesis and will accelerate early phase trial activities. D'Ambrosio also touches on ConcertAI's value of partnering. Biomedical innovations is a team sport. It requires the inputs of multiple types of expertise. It's in the dynamics operating as a single company or single entity that we can really transform the performance of research activities.Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

The ConcertAI Podcast is a monthly podcast which brings together subject matter experts who take a deeper dive on topics of interest and relevance like real world data, real world evidence, clinical development technologies and patient facing solutions for clinical diagnosis.To learn more please visit us at www.ConcertAI.comWebsitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai